The Coming GLP-1 Buying Shift That’s Causing Brands to Panic

The big story of GLP-1 medications has routinely been about weight loss, obesity and expanded usages beyond its original classification as a way to manage diabetes. A key element of how they work is to reduce cravings and impulsive choices when it comes to food. ​More recent data is starting to emerge​ that these effects may not only affect the way people buy and consume food. As Retail Prophet founder Doug Stephens puts it:

“You could almost look at the entire consumer market and say that an...